By Sam Boughedda After a dip earlier in the session, AbbVie (NYSE:ABBV) shares are now slightly up on the day, holding steady, despite Amgen (NASDAQ:AMGN) announcing AMJEVITA, a...
By Patrick Wingrove (Reuters) – U.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug Humira this year, but the cost savings are...
The prospects of three stocks that are ideal for rising passive income.
A look at 12 “forever” stocks coming from various industries, including technology, healthcare, and consumer goods, with solid track records of growth and stability.
20 Dividend Aristocrats that have market-beating dividend yields. They also have high-quality business models, durable competitive advantages, and long-term growth potential.
AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).
| Average | 162.87 (+12.17% Upside) |
| High | 200.00 |
| Low | 135.00 |
| Price | 145.20 |
| No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Buy | Strong Sell | Sell | Strong Sell | Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 6.81 | 6.79 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 60.33 | 60.40 | 59.15 | +1.10 | +1.86% | 1.78M | Toronto | |||
| 1.22 | 1.27 | 1.21 | -0.05 | -3.94% | 279.18K | Toronto | |||
| 0.165 | 0.165 | 0.165 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 9.71 | 9.71 | 9.70 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 13.64 | 13.65 | 13.58 | +0.03 | +0.22% | 75.83K | Toronto | |||
| 18.26 | 18.26 | 18.26 | -0.15 | -0.81% | 100.00 | Toronto | |||
| 0.075 | 0.08 | 0.075 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 4.98 | 4.98 | 4.97 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 1.07 | 1.08 | 1.06 | -0.0100 | -0.93% | 109.66K | Toronto | |||
| 18.27 | 18.27 | 18.10 | +0.16 | +0.88% | 23.08K | Toronto | |||
| 0.075 | 0.075 | 0.07 | -0.0050 | -6.25% | 20.00K | TSXV | |||
| 0.015 | 0.02 | 0.015 | 0.00 | 0.00% | 47.40K | CSE | |||
| 0.39 | 0.395 | 0.385 | +0.0100 | +2.63% | 123.94K | TSXV | |||
| 10.47 | 10.47 | 10.47 | 0.00 | 0.00% | 0.00 | Toronto |